Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Brady Corp
BRC
$4.46B
| $47.3M | 0.02% |
640,426
-6,659
| -1% | -$495K |
|
402
Macerich
MAC
$7.4B
| $45.4M | 0.02% |
2,276,219
-674,005
| -23% | -$13.2M |
|
403
Driven Brands
DRVN
$2.47B
| $44.7M | 0.02% |
2,770,158
-394,628
| -12% | -$6.19M |
|
404
NewAmsterdam Pharma
NAMS
$3.26B
| $44.7M | 0.02% |
1,736,777
+196,048
| +13% | +$4.16M |
|
405
Ball Corp
BALL
$17.5B
| $44.6M | 0.02% |
808,162
+100,883
| +14% | +$6.18M |
|
406
Pinduoduo
PDD
$126B
| $44.2M | 0.02% |
455,266
+355,712
| +357% | +$41.4M |
|
407
Citigroup
C
$213B
| $44.1M | 0.02% |
626,815
-326,094
| -34% | -$22M |
|
408
Entegris
ENTG
$16.3B
| $43.8M | 0.02% |
442,065
+9,676
| +2% | +$1.02M |
|
409
Lincoln Electric
LECO
$14.1B
| $43.5M | 0.02% |
232,013
+32,993
| +17% | +$6.65M |
|
|
NVO
410
Novo Nordisk
NVO
$228B
| $42.7M | 0.02% |
496,088
-396,339
| -44% | -$42.9M |
|
411
Westlake Corp
WLK
$9.26B
| $42.7M | 0.02% |
372,196
+170,791
| +85% | +$22.2M |
|
412
CG Oncology
CGON
$6.1B
| $42.6M | 0.02% |
1,485,843
-40,691
| -3% | -$1.39M |
|
413
Ametek
AME
$53.9B
| $42.2M | 0.02% |
234,059
-30,854
| -12% | -$5.62M |
|
414
Nordson
NDSN
$16.4B
| $42M | 0.02% |
200,953
+2,715
| +1% | +$671K |
|
415
CRA International
CRAI
$1.23B
| $41.7M | 0.02% |
222,570
+24,648
| +12% | +$4.69M |
|
416
Sanofi
SNY
$107B
| $41.6M | 0.02% |
862,520
-19,162
| -2% | -$974K |
|
417
Thor Industries
THO
$4.06B
| $41.5M | 0.02% |
433,768
+4,410
| +1% | +$471K |
|
418
Graphic Packaging
GPK
$3.35B
| $41.1M | 0.02% |
1,513,470
-184,042
| -11% | -$5.32M |
|
|
CRGX
419
DELISTED
CARGO Therapeutics
CRGX
| $40.9M | 0.02% |
2,830,544
+155,259
| +6% | +$2.82M |
|
|
WCN
420
Waste Connections
WCN
$43.6B
| $40.9M | 0.02% |
238,081
-1,330
| -0.6% | -$242K |
|
421
Ibotta
IBTA
$618M
| $40.8M | 0.02% |
626,905
+154,815
| +33% | +$10.8M |
|
422
DexCom
DXCM
$29B
| $40.6M | 0.02% |
521,812
-34,369
| -6% | -$2.54M |
|
423
OneMain Financial
OMF
$7.27B
| $40.5M | 0.02% |
776,649
+3,785
| +0.5% | +$196K |
|
424
Columbia Banking Systems
COLB
$8.71B
| $40.4M | 0.02% |
1,496,646
-766,786
| -34% | -$22M |
|
425
Toll Brothers
TOL
$14B
| $40.3M | 0.02% |
320,329
+17,682
| +6% | +$2.63M |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.